Back to Search
Start Over
Can serum IL-6 be a sentinel biomarker of cancer cachexia in gynecologic cancer patients?
- Source :
- Journal of Clinical Oncology. 36:e17544-e17544
- Publication Year :
- 2018
- Publisher :
- American Society of Clinical Oncology (ASCO), 2018.
-
Abstract
- e17544Background: Cancer cachexia occurs in approximately 80% of cancer patients, and is the primary cause of death for 22–30% of all cancer patients. Cancer cachexia also diminishes quality of lif...
- Subjects :
- 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
030109 nutrition & dietetics
biology
business.industry
digestive, oral, and skin physiology
Cancer cachexia
Cancer
musculoskeletal system
medicine.disease
03 medical and health sciences
Internal medicine
Gynecologic cancer
biology.protein
Medicine
Biomarker (medicine)
business
Interleukin 6
hormones, hormone substitutes, and hormone antagonists
Cause of death
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........e2a08e628c672f9fc00e041bbfe4d5a5
- Full Text :
- https://doi.org/10.1200/jco.2018.36.15_suppl.e17544